These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 498294)

  • 1. [Estimation of the degradation products of fibrinogen and fibrin (DPF) in malignant gynecological tumours (author's transl)].
    Kudela M; Fisherová E; Krc I
    Cesk Gynekol; 1979 Jul; 44(6):413-6. PubMed ID: 498294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen degradation products in gynecologic neoplasms].
    Tatra G; Breitenecker G; Karsai I
    Fortschr Med; 1976 May; 94(13):752-4. PubMed ID: 955534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of anesthesia and surgery on serum and urinary fibrinogen/fibrin degradation products (FDP) levels in man (author's transl)].
    Shinozaki Y; Takiguchi M; Oyama T
    Masui; 1978 Mar; 27(3):253-9. PubMed ID: 650865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preoperative determination of fibrin degradation products (FDP) in the sera of patients with suspected gynecologic tumors].
    Andersen HJ; Marushak A
    Ugeskr Laeger; 1985 May; 147(21):1689-91. PubMed ID: 4024309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on latex agglutination test for fibrin degradation products (author's transl)].
    Isobe J; Hamai Y; Taharaguchi T; Watanabe H; Kusumoto M; Saito S
    Rinsho Byori; 1977 Oct; 25(10):843-7. PubMed ID: 599703
    [No Abstract]   [Full Text] [Related]  

  • 9. [Examination of fibrin degradation products in cirrhosis of liver (author's transl)].
    Pstruzinová H; Rovenská A; Goderová Z; Kristan M
    Cas Lek Cesk; 1980 Jan; 119(1):7-11. PubMed ID: 7371051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P; Salazar R
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on high molecular weight fibrinogen/fibrin complex (HMWFC) (author's transl)].
    Suzuki S; Matsui N
    Rinsho Ketsueki; 1979 Aug; 20(8):901-9. PubMed ID: 502006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 13. [The relationship between the estimation of fibrin fibrinogen degradation products and euglobulinolytic test and its clinical significance (author's transl)].
    Xue ZM
    Zhonghua Nei Ke Za Zhi; 1981 Feb; 20(2):92-4. PubMed ID: 6118244
    [No Abstract]   [Full Text] [Related]  

  • 14. [alpha2 AP glycoprotein (PZP) in malignant gynecological tumours (author's transl)].
    Kudela M; Rozprimová L; Faltýnek L; Fischerová E; Krc I
    Cesk Gynekol; 1978 Aug; 43(7):501-6. PubMed ID: 679308
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetic movement of fibrin monomer (soluble fibrin monomer complex. S.F.M.C.) in cases of asphyxiated newborn (author's transl)].
    Suzuki S
    Rinsho Ketsueki; 1979 Jul; 20(7):740-4. PubMed ID: 501998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cesarean section and FDP (author's transl)].
    Konishi K; Niitsu T; Taguchi H; Muneyuki M
    Masui; 1978 Oct; 27(10):1071-5. PubMed ID: 702785
    [No Abstract]   [Full Text] [Related]  

  • 17. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E
    Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
    [No Abstract]   [Full Text] [Related]  

  • 18. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
    Hafter R; Schröck R; von Hugo R; Graeff H
    Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The detection of serum and urine fibrin and fibrinogen degradation products by hemagglutination inhibition test (author's transl)].
    Wang Z
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):330-3. PubMed ID: 555935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.